MRVI R&D to Revenue
Maravai Lifesciences Holdings Inc · R&D to Revenue
MRVI R&D to Revenue
Latest reported7.20%period ending
MRVI Quarterly R&D/Revenue (2.72% → 7.20%)
Latest values, visible window
High-resolution chart · PNG
MRVI r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 7.1965% | |
| 5.907% | |
| 7.5964% | |
| 23.4687% | |
| 10.3002% | |
| 10.4333% | |
| 8.086% | |
| 6.6626% | |
| 7.1989% | |
| 7.8406% | |
| 6.1963% | |
| 6.5012% | |
| 6.0858% | |
| 5.2452% | |
| 2.4478% | |
| 2.8176% | |
| 1.7608% | |
| 1.5125% | |
| 4.0154% | |
| 0.9501% | |
| 0.8858% | |
| 1.4574% | |
| 2.127% | |
| 2.1261% | |
| 3.4112% | |
| 7.3439% | |
| 2.7225% |